Nearly 80 years after the widespread introduction of antibiotics, the rapid rise of drug-resistant infections urgently calls for the development of novel antimicrobial therapies. Addressing bacterial infections through innovative preventive and curative approaches is among the United Nations targets for sustainability. It is paramount to identify treatments that minimize the risk of evolving resistance, ensuring long-term efficacy.